Evelyn Cheng / CNBC ·
Hong Kong-listed AI drug discovery company Insilico Medicine and Eli Lilly sign a drug co-development deal worth up to $2.75B, with $115M in upfront payments
BEIJING
Every Insilico Medicine story
1 story tracking Insilico Medicine, ranked newest first, from TechSnif's permanent archive.
Company